Related by context. All words. (Click for frequent words.) 79 p = #.# [002] 78 p = #.# [004] 77 p = 76 % CI #.#-#.# [007] 76 confidence interval CI 76 % CI #.#-#.# [002] 75 p = .# [002] 75 CI -#.# 75 % CI #.#-#.# [006] 74 % CI #.#-#.# [003] 73 placebo p = 72 confidence interval #.#-#.# 72 -#.# ± [002] 72 CI #.#-#.# [002] 72 biochemical recurrence 72 posttreatment 72 CI = 72 % CI #.#-#.# [008] 71 p = NS 71 LVEF 71 interquartile range 71 univariate analysis 71 P ≤ 71 PaO 2 71 postop 70 hip BMD 70 intima media thickness 70 % Confidence Interval 70 oxycodone CR 70 placebo p 70 n = 70 left ventricular systolic 70 p = .# [001] 70 lumbar spine BMD 69 ≥ 69 median PFS 69 PSA nadir 69 postintervention 69 postoperatively 69 % CI #.#-#.# [001] 69 MADRS score 69 preoperative PSA 69 posttransplant 69 MACCE 68 biochemical relapse 68 HbA 1c levels 68 postoperative complication 68 endometrial thickness 68 lopinavir r arm 68 p = #.# [003] 68 nonsignificant difference 68 pT3 68 pg ml 68 highest tertile 68 lowest tertile 68 tirofiban 68 statistically significant p = 68 CI #.#-#.# [001] 68 detrusor 68 pg mL 68 pmol L 68 nonsignificant 68 euthyroid 68 μmol L 68 femoral neck BMD 68 colorectal adenoma 68 preoperatively 68 creatinine ratio 68 tertile 67 nonfatal MI 67 5-FU/LV 67 leukopenia 67 MMSE score 67 nondiabetic patients 67 ropivacaine 67 receiving VICTRELIS 67 sd = 67 CR nPR 67 liver histology 67 statistically significant p 67 #.#/#.# mmHg [001] 67 detrusor overactivity 67 #.#ng/ml 67 preoperative 67 p ≤ 66 nmol liter 66 tertiles 66 multivariate adjustment 66 â ‰ ¥ 66 EBRT 66 SGRQ 66 mIU L 66 binary restenosis 66 ‰ ¥ 66 Secondary endpoints included 66 plus medroxyprogesterone acetate 66 periprocedural 66 Postoperative 66 mL/min/#.# m 2 66 serum concentrations 66 alanine aminotransferase 66 perioperatively 66 nonobese 66 mcg QD 66 severe neutropenia 66 x ULN 66 achieved statistical significance 66 leucopenia 66 Kaplan Meier analysis 66 intact parathyroid hormone 66 ipsilateral stroke 66 ipsilateral 66 #mg BID [001] 65 locoregional recurrence 65 seminal vesicle invasion 65 #mg/day [001] 65 CC genotype 65 MMSE scores 65 cerebral oxygenation 65 FOLFIRI alone 65 noncardiac 65 4mg/kg 65 -#.# mg dL [001] 65 mcg BID 65 confidence intervals CIs 65 lymph node metastasis 65 clodronate 65 definite stent thrombosis 65 postoperative 65 progression TTP 65 advanced adenoma 65 tolterodine ER 65 Preoperatively 65 NYHA functional class 65 Postoperatively 65 LV ejection fraction 65 timepoints 65 transaminase elevations 65 perioperative complications 65 postprocedure 65 adjunctive placebo 65 lymphopenia 65 mg QD 65 ± 65 HBeAg negative patients 65 log# copies mL 65 refractory ischemia 65 serum estradiol 65 methotrexate monotherapy 65 TT genotype 65 FOLFOX4 65 Stent thrombosis 65 WOMAC pain 65 TURBT 65 extrapyramidal symptoms 65 contralateral 65 μg mL 64 HOMA IR 64 diameter stenosis 64 nodal metastases 64 nadroparin 64 recurrent VTE 64 ± SD 64 mg kg dose 64 femoral neck fracture 64 QTcF 64 HBeAg seroconversion 64 IPSS 64 postoperative morbidity 64 PANSS scores 64 β = 64 Hazard Ratio HR 64 preintervention 64 lymphadenectomy 64 HbA1C levels 64 paresthesias 64 multivariable adjusted 64 PCWP 64 pCR 64 carotid IMT 64 lymphocytosis 64 coronary stenosis 64 mmHg diastolic 64 DAS# [002] 64 poststroke 64 nadolol 64 atheroma volume 64 mL kg 64 radical prostatectomy RP 64 #Gy 64 arterial thromboembolic events 64 nmol 64 symptomatic VTE 64 dyspareunia 64 univariate analyzes 64 dalteparin 64 thromboembolic events 64 normotensive 64 placebo 64 vasopressor 64 morphometric vertebral fractures 64 inotropic 64 TEAEs 64 NMIBC 64 NNT = 64 -#.# mg dL [002] 64 reintervention 64 leukocyte count 64 extracapsular extension 64 ejection fractions 64 achieved ACR# 64 Index CDAI 64 dyspnoea 64 multivariable analysis 64 parenchymal 64 mg TID 64 ng mL 64 Median PFS 64 hypokalemia 64 statistically significant 64 #mmHg [001] 64 reinfarction 64 cytogenetic abnormalities 64 erythrocyte sedimentation rate 64 comparator arm 64 CK MB 64 receiving ISENTRESS 64 diastolic BP 64 laboratory abnormalities 64 spine BMD 64 QRS duration 63 arterial oxygen saturation 63 lymphovascular invasion 63 pulmonary capillary wedge 63 % CI #.#-#.# [004] 63 lactate dehydrogenase 63 virologic response 63 elevated ALT 63 HbA 1c 63 affective psychosis 63 CrCl 63 chlorambucil 63 β blockers 63 pulmonary arterial 63 BMI z 63 μg liter 63 adrenalectomy 63 desvenlafaxine succinate 63 deep venous thromboses 63 left ventricular LV 63 PSADT 63 SGPT 63 LV dysfunction 63 radiotherapy RT 63 r = 63 multivariate Cox 63 alanine aminotransferase ALT 63 invasive carcinomas 63 mIU ml 63 primary patency 63 baseline HbA1c 63 Flu Cy 63 neutrophil counts 63 Visual Analogue Scale VAS 63 Operative mortality 63 dyspnea 63 ecchymosis 63 intratympanic 63 lymphocyte count 63 PCa 63 corrected QT interval 63 serum IGF 63 SUVmax 63 IM progesterone 63 fasting insulin 63 tipranavir r 63 neutrophil count 63 pericardial effusion 63 Univariate analysis 63 advanced adenomas 63 undetectable HBV DNA 63 SCr 63 hematologic toxicity 63 glycated hemoglobin HbA1c 63 thromboembolic 63 fractional anisotropy 63 pulmonary vascular 63 thromboembolism 63 homozygotes 63 splenic 63 MetS 63 T2 lesion volume 63 OAB symptoms 63 vasomotor 63 echocardiographic parameters 63 neurodevelopmental impairment 63 p = ns 63 systolic dysfunction 63 ischemia driven 63 angiographically 63 rheumatoid factor 63 = #.#-#.# 63 elevated transaminases 63 serum creatinine levels 63 thyroglobulin 63 distant metastases 63 nonischemic cardiomyopathy 63 nicardipine 63 adenoma recurrence 63 MBq 63 hemoglobin A1c levels 63 stent binary restenosis 63 multivariate analysis 63 Psoriasis Area 63 interquartile range IQR 63 pamidronate 63 hyperintensity 63 nmol L 63 pT2 63 octreotide LAR 63 subscore 63 graft dysfunction 63 AOR = 63 Hazard Ratio = 63 hydronephrosis 63 nonmetastatic 63 endometrial carcinoma 63 REYATAZ r arm 63 nasopharyngitis headache 63 IIIa inhibitors 63 recurrent DVT 63 CsA 62 mild renal insufficiency 62 multivariate analyzes 62 cTnI 62 ALT elevation 62 symptomatic intracerebral hemorrhage 62 hemoglobin Hb 62 chemoradiation therapy 62 timepoint 62 Pred Forte 62 abacavir lamivudine 62 recurrent venous thromboembolism 62 hypophosphatemia 62 rCBF 62 HIV RNA 62 Viread Emtriva Sustiva 62 troponin T 62 % CI #.#-#.# [005] 62 g dl 62 flutamide 62 μg ml 62 hours postdose 62 postoperative AF 62 aspartate aminotransferase 62 biopsy Gleason 62 serum PTH 62 normothermic 62 cerebrovascular events 62 SLNB 62 NIHSS 62 crossclamp 62 TIMP 62 HbA1c levels 62 postoperative mortality 62 systolic BP 62 preoperative chemotherapy 62 lopinavir r 62 creatinine clearance 62 dysuria 62 tibiofemoral 62 serum albumin 62 mucosal inflammation 62 Cmax 62 transabdominal 62 underwent resection 62 fibrinolysis 62 umbilical artery 62 creatine kinase MB 62 methacholine challenge 62 plus methotrexate 62 urine albumin 62 Subgroup analysis 62 nausea photophobia 62 retropubic 62 placebo dexamethasone 62 ischemic lesions 62 AUC0 62 CI #.#-#.# p = 62 febrile neutropenia 62 HDRS 62 ventricular mass 62 femoral neck 62 platelet reactivity 62 glomerular filtration 62 Median progression 62 International Prostate Symptom 62 anemia hemoglobin 62 neoplasias 62 axillary node 62 PASI scores 62 subtrochanteric 62 nonoperative treatment 62 AST ALT 62 comorbidities 62 virologic failure 62 clinically meaningful improvement 62 nasopharyngitis 62 genotypic resistance 62 titrated glipizide 62 CCyR 62 androgen suppression 62 urinary albumin 62 β blocker 62 primary aldosteronism 62 uM 62 ovarian carcinoma 62 hypogonadal 62 CR CRu 62 atazanavir ritonavir 62 ng dL 62 aspartate aminotransferase AST 62 eptifibatide 62 PRADAXA #mg 62 WOMAC scores 62 unfractionated heparin 62 eplerenone 62 serum urate levels 62 eosinophil count 62 #mm Hg 62 leukocytosis 62 mild renal impairment 62 Thal Dex 62 specific antigen PSA 62 seronegative 62 histologic 62 mg d 62 RVOT 62 salivary flow 62 hematuria 62 symptomatic intracranial 62 FOLPI 62 mEq L 62 postoperative complications 62 cerebral infarction 62 intraabdominal 62 mg ustekinumab 62 ADAS cog 62 reoperation 62 tamsulosin 62 Hazard Ratio 62 hemodilution 62 HBeAg 62 budesonide pMDI 62 Apgar scores 62 Secondary endpoints 62 extracranial 62 mmHg p = 62 intravesical therapy 62 neointimal 62 mg/m2 dose 61 solifenacin 61 bronchoalveolar lavage 61 rebleeding 61 infarct size 61 tenecteplase 61 min -1 61 distant metastasis 61 sonographically 61 thrombocytopenic 61 tHcy 61 arterial occlusion 61 osteopenic 61 gadolinium enhanced 61 FDA defined valvulopathy 61 5FU 61 thyroid carcinoma 61 conjunctival hyperemia 61 μg kg 61 lumbar spine bone 61 Secondary endpoints include 61 recurrent UTI 61 anastomotic leak 61 mutated KRAS 61 #.#/#.# mm Hg [003] 61 acute cholecystitis 61 hyperintensities 61 #OHD 61 esophageal carcinoma 61 apnea hypopnea index 61 NSTEMI 61 nonischemic 61 plasma leptin 61 graft occlusion 61 femoral shaft fracture 61 tumor histology 61 univariate 61 hyperreflexia 61 fatigue asthenia 61 oxycodone IR 61 carotid intima media 61 systolic function 61 sonographically guided 61 perioperative mortality 61 nonobstructive 61 mL/min/#.# m2 61 Target Lesion Revascularization TLR 61 moderate renal impairment 61 FDG uptake 61 GERD symptom 61 hsCRP levels 61 androgen deprivation 61 serum cortisol 61 tapentadol ER 61 nonoperative 61 interobserver reliability 61 mL sec 61 nasal obstruction 61 Serum creatinine 61 GG genotype 61 CIN3 61 aOR 61 extensive metabolizers 61 plasma uric acid 61 #q# deletion syndrome 61 discontinuations due 61 noninferior 61 mmol L 61 Kaplan Meier curves 61 TAXUS p value 61 systolic blood pressures 61 postinjury 61 urothelial carcinoma 61 FluCAM arm 61 LAB GHRH 61 proximal DVT 61 serum TSH 61 neurologic progression 61 salivary cortisol 61 renal insufficiency 61 anterior temporal 61 Pain Intensity 61 nondiabetic 61 lispro 61 logistic regression analysis 61 statistically significant reduction 61 subscale scores 61 nephrectomy 61 reach statistical significance 61 HAQ DI 61 parous women 61 hypoxemia 61 distensibility 61 dehydroepiandrosterone sulfate 61 attain statistical significance 61 VcMP 61 preterm neonates 61 #.#mg/dL 61 plasma adiponectin 61 mediastinal 61 irbesartan 61 serum ALT 61 EDSS score 61 fractional shortening 61 -#.# log# 61 pulmonary exacerbation 61 radical nephrectomy 61 nondepressed 61 unresectable HCC 61 RYGB 61 knee osteoarthritis OA 61 debulking surgery 61 multivariable analyzes 61 μg L 61 ALND 61 CYP#D# inhibitor 61 abdominal circumference 61 HRQoL 61 cerebrovascular accident 61 histological subtype 61 placebo fluoxetine 61 XIENCE V PROMUS Stent 61 pentoxifylline 61 prostate cancer CaP 61 operable breast cancer 61 TIMP 1 61 glycated hemoglobin levels 61 neutropaenia 61 T2 lesions 61 Doxil ® 61 Ishak fibrosis score 61 coronary revascularization 61 nonresponders 61 aminotransferases 61 mU liter 61 Zometa hazard 61 postoperative chemotherapy 61 lumen diameter 61 NIHSS score 61 Montgomery Åsberg Depression 61 progesterone receptor negative 61 hemodynamically significant 61 inflammatory lesions 61 chemoradiotherapy 61 Exclusion criteria 61 headache nasopharyngitis 61 lymphadenopathy 61 T1a 61 retransplantation 61 Visual Analog Scale 61 gastroduodenal 61 mmHg systolic 61 carotid stenosis 61 vesicoureteral reflux 61 hMG 61 gastrointestinal perforation 61 EDSS scores 61 serum potassium 61 colorectal carcinoma 61 isoproterenol 61 obstructive CAD 61 tricuspid regurgitation 61 LPV r 61 pegylated interferon alfa 2b 61 protein excretion 61 serum testosterone 61 severe exacerbations 61 serum HBV DNA 61 infliximab monotherapy 61 elevated LDH 61 jugular venous 61 abciximab 61 dobutamine 61 rFSH 61 pulmonary artery banding 61 racemic albuterol 61 Rating Scale MADRS 61 albumin excretion rate 61 ng ml 61 postoperative pulmonary 61 hypervascular 61 incidence ≥ 60 #.#mmol L [002] 60 ultrasonographic 60 serum PSA 60 NPH insulin 60 nonfatal myocardial infarction 60 clinicopathological features 60 axillary lymph node 60 bilateral oophorectomy 60 total thyroidectomy 60 Subgroup analyzes 60 urodynamic 60 plasma cortisol 60 covariate 60 -#.# ± [001] 60 certolizumab 60 hyperacute 60 intraobserver 60 adenoidectomy 60 nmol l 60 TKAs 60 mmol l 60 secondary endpoint 60 dose dependently 60 postsurgical 60 Complication rates 60 #mg BID [003] 60 #mg QD [001] 60 urolithiasis 60 metoprolol tartrate 60 CVD mortality 60 graft patency 60 Crohn Disease Activity 60 elevated IOP 60 asthma exacerbation 60 overt nephropathy 60 serum triglycerides 60 urinary N telopeptide 60 hepatic metastases 60 stage IIIb IV 60 beta blocker therapy 60 creatinine levels 60 Secondary efficacy endpoints 60 arteriolar 60 Multivariate analysis 60 6MWD 60 mRNA expression 60 oropharyngeal 60 logMAR 60 baseline LDH 60 neurocognitive function 60 phonophobia 60 dapagliflozin plus 60 total knee arthroplasty 60 ATACAND 60 hemodynamic parameters 60 locoregional 60 IFN alfa 60 amoxicillin clavulanate 60 #.#mmHg 60 mg p = 60 ertapenem 60 pooled comparator 60 LVSD 60 adenotonsillectomy 60 μg d 60 doxorubicin docetaxel 60 bivalirudin monotherapy 60 locoregional disease 60 ketorolac 60 serum urate 60 iodixanol 60 aPTT 60 symptom severity 60 aortic regurgitation 60 histologically 60 NIH CPSI 60 immunoreactivity 60 symptomatic AF 60 adjuvant radiotherapy 60 atrioventricular block 60 incontinence episodes 60 proteinuria 60 abdominal pain abdominal discomfort 60 cisplatin vinorelbine 60 Multivariate analysis showed 60 recurrent ischemia 60 urate lowering therapy 60 statistically significant differences 60 mcg Albuferon 60 primary percutaneous coronary 60 glomerular filtration rate 60 interobserver 60 papillary thyroid carcinoma 60 plasma folate 60 multivariate adjusted 60 intrahepatic 60 liver metastasis 60 mitoxantrone 60 leukocyte counts 60 VT VF 60 nonvertebral fracture 60 #ng/ml 60 Postoperative complications 60 cGy 60 IELT 60 Primary endpoints 60 extrapulmonary 60 hemorrhagic complications 60 TAXUS Express Stent 60 D dimer 60 -#.# mm Hg 60 subscales 60 revascularizations 60 hyperemia 60 GnRH agonist 60 concomitant antibiotics 60 serum leptin 60 depressive symptomatology 60 conjugated equine estrogen 60 baroreflex sensitivity 60 peri procedural 60 antibody titer 60 atorvastatin #mg 60 suprapubic 60 QTc 60 Leydig cell 60 FOLFOX4 alone 60 umol L 60 paclitaxel eluting stents 60 plasma creatinine 60 BEACOPP 60 nonobese patients 60 bosentan 60 albuminuria 60 peritumoral 60 autonomic dysfunction 60 TURP 60 clinically meaningful improvements 60 mcg mL 60 nM 60 plus GP IIb 60 interleukin IL -6 60 baseline Hb 60 left ventricular diastolic 60 Baseline characteristics 60 cerebral perfusion 60 8mg/kg 60 thromboembolic complications 60 sonographic appearance 60 pretransplant 60 prednisone prednisolone plus 60 sirolimus eluting stent 60 serum HCV RNA 60 creatine phosphokinase 60 glycoprotein IIb IIIa inhibitors 60 fraction LVEF 60 intravitreal injections 60 myocardial infarction MI 60 hemodynamics 60 tolterodine 60 splanchnic 60 treated nonoperatively 60 elevated troponin 60 Breslow thickness 60 surgically induced 60 urinary excretion 60 colon rectal 60 sirolimus stent 60 RLAI 60 intraperitoneal 60 PREZISTA ritonavir 60 mcg albinterferon alfa 2b 60 isoprostane 60 artery stenosis 60 μg dL 60 coronary stenoses 60 g dL 60 HF hospitalization 60 Kaplan Meier survival 60 FEV1 60 hemodynamic variables 60 ASCUS 60 estimated glomerular filtration 60 serum prostate 60 advanced neoplasia 60 diastolic blood pressures 60 revascularization procedures 60 statistical significance p 60 detectable HCV RNA 60 wound dehiscence 60 serum CRP 60 nonfasting triglyceride levels 60 kappa = 60 mitoxantrone plus 60 rs# [004] 60 collagenous colitis 60 lacunar 60 sUA 60 left ventricular dysfunction 60 Hb A1C 60 occlusive disease 60 C#BL/#J mice 60 prostate carcinoma 60 IIIa inhibitor 60 HBeAg positive patients 60 salpingo oophorectomy 60 serum sodium 60 ventricular dilatation 60 mm Hg systolic 60 radiographic findings 60 mg BID 60 aortic crossclamp 60 HRQOL 60 CIMZIA TM certolizumab pegol 60 calculi 60 ug kg 60 fluticasone salmeterol 60 ximelagatran 60 percutaneous transluminal coronary angioplasty 60 spontaneous bacterial peritonitis 60 elevated creatinine 60 cough dyspnea 59 Injury Severity Score 59 microg 59 GH deficiency 59 oxygen desaturation 59 renal pelvis 59 ANOVA 59 arteriography 59 ezetimibe simvastatin 59 mmol kg 59 neurologic outcomes 59 LNG IUS 59 neurologic deficits 59 antiretroviral naïve 59 gadolinium enhancing lesions 59 pretreatment baseline 59 generalized edema 59 tissue oxygenation 59 seropositivity 59 radical retropubic prostatectomy 59 nodal metastasis 59 patients undergoing CABG 59 adriamycin 59 Lumbar spine 59 pulmonary artery pressure 59 Preoperative 59 histologically confirmed 59 epistaxis 59 #mg/day [002] 59 Median survival 59 pneumonectomy 59 serum retinol 59 reactive hyperemia 59 esomeprazole 59 HER2 amplification 59 ug dose 59 infarcts 59 Doppler sonography 59 reoperations 59 pulsatility index 59 spirometric 59 dyssynchrony 59 Taxus Stent 59 DAS# scores 59 ALT normalization 59 bypass grafting 59 intratumoral 59 rho = 59 heterozygotes 59 TMP SMX 59 acetabular dysplasia 59 ABC/3TC 59 neostigmine 59 TPV r 59 carotid artery thickness 59 Ki# 59 colorectal neoplasms 59 nonvertebral fractures 59 distal radial fractures 59 Kruskal Wallis test 59 IOP lowering 59 antithymocyte globulin 59 severe hypoglycemic 59 fasting triglyceride levels 59 F FDG PET 59 log# 59 nulliparous women 59 cervical lymph nodes 59 URTI 59 activated partial thromboplastin 59 YMRS 59 submucosal 59 mRS 59 Partial Responses 59 Plasma concentrations 59 TAVR 59 hypoperfusion 59 hypervolemic 59 IQR 59 mucosal lesions 59 sensory neuropathy 59 Insulin sensitivity 59 chest radiograph 59 rs# [002] 59 asystole 59 coronary calcification 59 DHCA 59 cortical atrophy 59 PANSS total 59 sumatriptan naproxen sodium 59 regression coefficient 59 experienced virologic failure 59 serum uric acid 59 atherosclerotic renal artery stenosis 59 myocardial ischemia 59 cirrhotic 59 hormone receptor negative 59 DAS# remission 59 intramuscularly 59 hypoglycemic events 59 gm dL 59 malperfusion 59 UPDRS 59 carotid plaques 59 antral 59 macroalbuminuria 59 APTIVUS r 59 peripheral edema 59 paricalcitol 59 ATV RTV 59 EpCAM expression 59 hypertensives 59 achieved PASI 59 adjunctive ABILIFY 59 diastolic pressures 59 Patency 59 ventricular tachyarrhythmia 59 lateral radiograph 59 antiphospholipid antibodies 59 highest quintile 59 reflux esophagitis 59 luminal 59 vaginal hysterectomy 59 nasal symptom 59 noncarriers 59 acetazolamide 59 serum magnesium 59 saline placebo 59 ECOG PS 59 intestinal metaplasia 59 multivessel disease 59 undergoing liver transplantation 59 thrombotic complications 59 NYHA class 59 neoplasm 59 nonmetastatic prostate cancer